Back to search

Article

Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatment

2024-10-16

Abstract excerpt

Tumor treatment has entered a new phase because to cancer immunotherapy in recent years. For a variety of human diseases, researchers have been looking for ways to alter the immune system at different phases of treatment. Chimeric Antigen Receptor (CAR) therapy is a quickly developing cancer treatment that is a subset of adoptive cell treatments (ACT). By injecting CAR molecules into immune cells, this method gene...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6c414bb4-e3a0-5851-b70e-23286ee95059
DOI
10.22541/au.172908403.30180674/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatmentDOI 10.22541/au.172908403.30180674/v1
Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity
A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?Semantic proximity
NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentSemantic proximity
Advantages and clinical applications of natural killer cells in cancer immunotherapy.Semantic proximity
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedsideSemantic proximity
NKT cells - New players in CAR cell immunotherapy?Semantic proximity
Nonviral technologies can pave the way for CAR-NK cell therapySemantic proximity
Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer MethodologySemantic proximity
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapySemantic proximity
Natural Born Killers: NK Cells in Cancer TherapySemantic proximity
CAR-NK cell therapy: a potential antiviral platformSemantic proximity
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advancesSemantic proximity
Select a neighboring publication to make it the new centre.